Contextual factors, such as voice behavior and cultural differences, should be considered when ...

Author Question: Contextual factors, such as voice behavior and cultural differences, should be considered when ... (Read 130 times)

danielfitts88

Hero Member
Posts: 535

on: Jul 7, 2018

Contextual factors, such as voice behavior and cultural differences, should be considered when organizations choose to define and measure performance.

Indicate whether the statement is true or false

Question 2

Statements of important and measurable outcomes are called _______________.

A. key accountabilities
B. performance standards
C. objectives
D. yardsticks

kaillie

Sr. Member
Posts: 326

Reply #1 on: Jul 7, 2018

Answer to Question 1

T

Answer to Question 2

C

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.